🔗 Visit the ClinicalTrials.gov page for NCT01211262
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Bispecific antibodies and their applications. | J Hematol Oncol | 2015 | 0.92 |
| 2 | Bi-specific TCR-anti CD3 redirected T-cell targeting of NY-ESO-1- and LAGE-1-positive tumors. | Cancer Immunol Immunother | 2012 | 0.88 |
| 3 | Adoptive T-cell therapies for refractory/relapsed leukemia and lymphoma: current strategies and recent advances. | Ther Adv Hematol | 2015 | 0.82 |
| 4 | New clinical advances in immunotherapy for the treatment of solid tumours. | Immunology | 2015 | 0.76 |
| 5 | Chimeric antigen receptors and bispecific antibodies to retarget T cells in pediatric oncology. | Pediatr Blood Cancer | 2015 | 0.75 |